ArticleCancer science2017

Puquitinib, a novel orally available PI3Kδ inhibitor, exhibits potent antitumor efficacy against acute myeloid leukemia.

Chengying Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.